One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Seminal vesicle inter- and intra-fraction motion during radiotherapy for prostate cancer: A review
Victor J.BrandMaaike T.W.MilderMiranda E.M.C.ChristianenMischa S.Hoogeman1LucaIncrocci1
Anal cancer brachytherapy: From radon seeds to interstitial Papillon technique in a century. What does the future hold?
PrimozPetricacNooraAl-HammadibKaren-Lise GarmSpindlercJacob ChristianLindegaardc
Clinical necessity of multi-image based (4DMIB) optimization for targets affected by respiratory motion and treated with scanned particle therapy – A comprehensive review
Antje-ChristinKnopfabcdKatarzynaCzerskaecFrancescoFracchiollafcChristianGraeffghcSilviaMolinelliicIlariaRinaldijcAntoniRucinckiecEdmondSterpinklcKristinStützermncPetraTrnkovaocYeZhangacdJoe YChangpdHuanGiapqdWeiLiurdSteven ESchildrdCharles B.SimoneIIsdAntony JLomaxtcdArtursMeijersad
Innovation, value and reimbursement in radiation and complex surgical oncology: Time to rethink
Josep M.BorrasabcJulietaCorralbcAjayAggarwaldRiccardoAudisioeJosep AlfonsEspinasbcJosepFiguerasfPeterNaredigDimitraPantelihNicolasPoureliJoanPradesbcYolandeLievensj
Durvalumab with cetuximab and radiotherapy for locally advanced squamous cell carcinoma of the head and neck: A phase 1/2 trial
PierluigiBonomoaIsaccoDesideriaMonicaMangoniaCalogeroSaievabMauroLoiaCarlottaBecheriniaCeciliaCerbaiaMicheleGanovelliaViolaSalvestriniaGiuliaStocchiaMargheritaZanicAnnaritaPalombadLorenzoLivia
Detailed patient-individual reporting of lymph node involvement in oropharyngeal squamous cell carcinoma with an online interface
RomanLudwiga1Jean-MarcHoffmanna1BertrandPouymayoua1Martina BroglieDäppenbGrégoireMorandbMatthiasGuckenbergeraVincentGrégoirecPanagiotisBalermpasaJanUnkelbacha
Biomarker signatures for primary radiochemotherapy of locally advanced HNSCC – Hypothesis generation on a multicentre cohort of the DKTK-ROG
SteffenLöckabcAnnettLingeabcdFabianLohausabcdNadjaEbertabceVolkerGudzioldfAlexanderNowakdgIngeborgTinhoferhiGodaKalinauskaitehiMajaGuberinajkMartinStuschkejkPanagiotisBalermpaslmJensvon der GrünlmAnca-LigiaGrosunoJürgenDebuspqrstUteGanswindtuvwxClausBelkauvwJan C.PeekenuyzStephanie E.Combsuyz…MichaelBaumannabe
Dosimetric parameters related to occurrence of distant metastases and regional nodal relapse after SBRT for early-stage non-small cell lung cancer
RonaldLalondeMohamedAbdelhakiemAndrewKellerM. SaifulHuq
Major adverse cardiac event risk prediction model incorporating baseline Cardiac disease, Hypertension, and Logarithmic Left anterior descending coronary artery radiation dose in lung cancer (CHyLL)
Michael C.Tjongabc2Danielle S.BittermanbKristenBrantleycAnjuNohriadUdoHoffmanneKatelyn M.Atkinsbf1Raymond H.Makb1
Early PSA density kinetics predicts biochemical and local failure following extreme hypofractionated radiotherapy in intermediate-risk prostate cancer
CarloGrecoaOriolParesaNunoPimentelaVascoLouroaBeatrizNunesaJustynaKociolekaJoãoMarquesaZviFuksab
Two-fraction stereotactic ablative radiotherapy (SABR) versus two-fraction high dose rate (HDR) brachytherapy for localized prostate cancer: Does dose heterogeneity matter?
Rohann J.M.CorreaabGerardMortonabHans T.ChungabChia-LinTsengabPatrickCheungabWilliamChuabStanley KLiuabMerryleeMcGuffinabAnamShahidaMelanieDavidsonabAnanthRavicJoelleHeloubdYasirAlayedaeLiyingZhangaAlexandreMamedovaAndrewLoblawabf
Timing of Ga68-PSMA PETCT and patterns of recurrence after prostate radiotherapy: Implications for potential salvage
PriyamvadaMaitreaSahilSoodaPriyankaPathareaRahulKrishnatryaArchiAgrawalbVenkateshRangarajanbVedangMurthya
Computer-aided segmentation on MRI for prostate radiotherapy, Part I: Quantifying human interobserver variability of the prostate and organs at risk and its impact on radiation dosimetry
Jeremiah W.Sandersa1HenryMokbAlexander N.HananiacAradhana M.VenkatesandChadTangbTeresa L.BrunobHoward D.Thamese1Rajat J.KudchadkerfSteven J.Frankb
Computer-aided segmentation on MRI for prostate radiotherapy, part II: Comparing human and computer observer populations and the influence of annotator variability on algorithm variability
Jeremiah W.SandersaHenryMokbAlexander N.HananiacAradhana M.VenkatesandChadTangbTeresa L.BrunobHoward D.ThameseRajat J.KudchadkerfSteven J.Frankb
Technical challenges in the treatment of mediastinal lymphomas by proton pencil beam scanning and deep inspiration breath-hold
RobertoRighettoaFrancescoFracchiollaaLambertoWidesottaStefanoLorentiniaFrancescoDionisibBarbaraRombiaDanieleScartoniaSabinaVennariniaMarcoSchwarzacPaoloFaracea
Deep learning driven predictive treatment planning for adaptive radiotherapy of lung cancer
DonghoonLeeaYu-chiHuaLichengKuoaSadeghAlamaEllenYorkeaAnyiLiaAndreasRimnerbPengpengZhanga
Radiomics-based tumor phenotype determination based on medical imaging and tumor microenvironment in a preclinical setting
JohannesMüllerab1StefanLegerac1AlexZwanenburgacTheresaSuckertadArminLühraeElkeBeyreutherafClärevon NeubeckagMechthildKrauseabchSteffenLöckahAntjeDietrichadRebeccaBütofach
A novel treatment for malignant spasticity: The therapeutic use of stereotactic radiosurgery (SRS)
LucaNicosiaaElenaRossatobRenatoAvesanibFabioMarchiorettocGiuseppeArmanibMassimoZamperinidGiovanniFotieFatemehJafarifAntonioDe SimoneaRuggeroRuggieriaFilippoAlongiagFedericoFerrarib
In response to Finazzi and Papachristofilou
Clayton B.HessMohammad K.Khan
Comment on “Photobiomodulation therapy for the prevention of acute radiation dermatitis (ARD) in head and neck cancer patients (DERMISHEAD trial)�
JianHeabLitingQianabJinGaoab
Response to the Comment on “Photobiomodulation therapy for the prevention of acute radiation dermatitis (RD) in head and neck cancer patients (DERMISHEAD trial)� by He et al.
JolienRobijnsaJoyLodewijckxaStefanClaesbLeenVan BeverbLucPannekoekebSandrineCensabellabLoreBusséaDoraColsonaIrisKaminskiaVictoriaBrouxaSofiePutsaSofieVanmechelenaAnTimmermanscLeenNoébPaulBulensbMiekeGoversdAnneliesMaesbdJeroenMebisae
Head and neck cancer diagnoses and faster treatment initiation during COVID-19: Correspondence
RujittikaMungmunpuntipantipaVirojWiwanitkitb
Response to “Head and neck cancer diagnoses and faster treatment initiation during COVID-19: Correspondence�
Rosanne C.Schoonbeeka1Dominique V.C.de Jelbc1Boukje A.C.van DijkdeStefan M.WillemsfElisabethBloemenagFrank J.P.HoebershEsthervan MeerteniBerit M.VerbistjLudi E.SmeeleckGyörgy B.HalmosaMatthias A.W.MerkxdlSabineSieslingdmRemcoDe BreenRobert P.Takesoon behalf of the Dutch Head and Neck Society and the COVID and Cancer-NL consortiumo
Testosterone levels and testosterone kinetics: The importance of its clinical significance
AlmudenaZapatero
The importance of appropriate castrate level measurements of serum testosterone in prostate cancer patients
JuanMorote
Letter to the editor regarding the article “Definitive chemoradiotherapy versus neoadjuvant chemoradiotherapy and esophagectomy for the treatment of esophageal and gastroesophageal carcinoma – A systematic review and meta-analysis� by Chow et al.
JieZhuabYanTanabQifengWangab
Response to Zhu et al re “Definitive chemoradiotherapy versus neoadjuvant chemoradiotherapy and esophagectomy for the treatment of esophageal and gastroesophageal carcinoma - A systematic review and meta-analysis�
RonaldChowabKyleMurdybMarcusVaskasbSangjune LaurenceLeeb
Palliative radiotherapy for cancer patients with interstitial lung disease: A physician's perspective
SatoshiIkeda
Response to palliative radiotherapy for cancer patients with interstitial lung disease: A physician's perspective
MasayukiOkumuraacHidehiroHojobcTetsuoAkimotobc
Stereotactic radiotherapy needs more evidence before it can be used routinely to treat metastases: A comment on the paper by Nicosia et al
FergusMacbethaNormanWilliamsbTomTreasurec
Reply to: Stereotactic radiotherapy needs more evidence before it can be used routinely to treat metastases: A comment on the paper by Nicosia et al
LucaNicosiaaBarbara AlicjaJereczek-FossabcMicheleRigoaMartaScorsettideMattia FalchettoOstifFrancoCasamassimagFilippoAlongiah
Comment to “Definitive chemoradiotherapy versus neoadjuvant chemoradiotherapy and esophagectomy for the treatment of esophageal and gastroesophageal carcinoma – A systematic review and meta-analysis�
Yung-ShuoKaoaYi-FangChenb
Response to Kao and Chen
RonaldChowKyleMurdyMarcusVaskaSangjune LaurenceLee
Corrigendum to “Definitive chemoradiotherapy versus neoadjuvant chemoradiotherapy and esophagectomy for the treatment of esophageal and gastroesophageal carcinoma – A systematic review and meta-analysis� [Radiother. Oncol. 165 (2021) 37–43]
RonaldChowab1KyleMurdya1MarcusVaskaaSangjune LaurenceLeea
Corrigendum to “DCE-MRI quantitative transport mapping for noninvasively detecting hypoxia inducible factor-1α, epidermal growth factor receptor overexpression, and Ki-67 in nasopharyngeal carcinoma patients� [Radiother Oncol (2021) 164:146-154]
WeiyuanHuangab1QihaoZhangbd1GangWue1PianpianChenfJiaoLifKellyMcCabe GillenbPascalSpincemaillebGloria CChiangcAjayGuptacYiWangbdFengChena
